Shilpa Medicare gets 10 observations from USFDA for its formulation plant in Telangana News News / News 6 years ago 496 Views comments The company said out of 10 observations, seven were related to improvement in procedures and practices, while the three others were regarding analytic... Read more
News Bull#39;s Eye: Buy Infosys, Wipro, Tata Comm, Britannia, HDIL; sell Castrol, Bank of India News / News - 6 years ago
Comments